North America and Europe Artificial Pancreas Systems Market
Market Insights on North America and Europe Artificial Pancreas Systems covering sales outlook, demand forecast & up-to-date key trends
North America and Europe Artificial Pancreas Systems Market By Distribution Channel Type (Hospitals, E-Commerce), Disease Indication (Diabetes Type 1, Diabetes Type 2) & Region - Forecast to 2016 - 2026
Diabetes Type 1 segment is likely to prevail over Diabetes Type 2 segment in the North America and Europe artificial pancreas systems market
The Diabetes Type 1 segment was estimated to account for a little more than 95% market share in terms of value in the North America and Europe artificial pancreas systems market by 2016 end and is expected to experience an increase of more than 200 BPS in its market share by 2026 over 2016.
The Diabetes Type 1 segment is expected to register high Y-o-Y growth rates throughout the forecast period. Revenue contribution of this segment is projected to increase at a CAGR of 12.6% over the forecast period to reach more than US$ 250 Mn by 2026. On the other hand the Diabetes Type 2 segment is expected to register low Y-o-Y growth rates throughout the forecast period.
Revenue contribution of this segment to the North America and Europe artificial pancreas systems market is expected to increase at a CAGR of 4.1% over the forecast period. The Diabetes Type 1 segment dominated the North America and Europe artificial pancreas systems market in revenue terms in 2015, and the trend is projected to continue throughout the forecast period.
The Diabetes Type 2 segment is expected to remain the least attractive segment in the North America and Europe artificial pancreas systems market in revenue terms with a low market attractiveness index of 0.02 over the forecast period.
Let us know your requirement to get
100% FREE customization
Alarming rise in population and economic burden of diabetes worldwide is anticipated to impact the artificial pancreas systems market in North America and Europe
Diabetes is one of the chronic and life-threatening diseases that affects a large part of the global population. Diabetes, also known as diabetes mellitus, is a metabolic disorder wherein the pancreas are either not able to produce insulin or the body is not able to utilise the existing insulin to metabolise glucose. Insulin is an essential secretion (hormone) of the body that metabolises glucose received by the body during and after a meal. An increasing burden of managing and controlling diabetes is the most important factor prompting demand for artificial pancreas systems among the global diabetic population.
Conventional systems used for diabetes management have many drawbacks including the need to take insulin injections at multiple times and recalibrating the CGM devices, thereby making management of diabetes quite tedious. However, artificial pancreas systems are designed to be more portable and user friendly. Artificial pancreas systems are technologically advanced.
On the other hand, the conventional insulin pumps or CGM devices are large in size and thus, people have social and psychological stigma regarding conventional insulin devices, which motivates them to opt for artificial pancreas systems. This particular factor is creating a robust development in the North America and Europe artificial pancreas systems market.
Artificial pancreas systems are envisioned to deliver a complete system known as a closed loop system that mimics a pancreatic activity of maintaining blood glucose levels by coalescing several technologies including a glucose monitoring device, a glucose sensor with cutting-edge algorithm software and an insulin pump. Manufacturers are competing to provide such high-end artificial pancreas systems to attract diabetic patients who intend to improve diabetes management.
Diabetes Type 1 segment is projected to dominate the North America and Europe artificial pancreas systems market throughout the period of assessment
Diabetes Type 1 disease indication segment dominated the North America artificial pancreas systems market in revenue terms in 2015 and is projected to continue to do so throughout the forecast period, recording a market attractiveness index of 2.0. In Western and Eastern Europe this segment is expected to remain the dominant disease indication segment throughout the projected period.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystNorth America and Europe artificial pancreas systems market: segmentation
By Region:
- North America
- Western Europe
- Eastern Europe
By Distribution Channel:
- Hospitals
- E-Commerce
By Disease Indication:
- Diabetes Type 1
- Diabetes Type 2
A unified Market Research Subscription Platform, built for today's disparate research needs.
Frequently Asked Questions
Demand for North America and Europe artificial pancreas systems is likely to grow at a CAGR of 12% through 2032.
Sales of North America and Europe artificial pancreas systems is likely to exceed a valuation of US$ 567.47 million by 2032.
Adoption of North America and Europe artificial pancreas systems is likely to reach a valuation of US$ 182.71 million in 2022.
Upsurge in the case of type-1 diabetes is leading to North America and Europe artificial pancreas systems market growth.
Table of Content
1. Executive Summary
2. Market Introduction
2.1. Market Definition
2.2. Market Taxonomy
3. North America and Europe Artificial Pancreas Device System Market Analysis Scenario
3.1. Market Size (US$ Mn) and Forecast
3.1.1. Market Size and Y-o-Y Growth
3.1.2. Absolute $ Opportunity
3.3. Market Overview
4. Market Dynamics
4.1. Macro-economic Factors
4.2. Drivers
4.2.1. Supply Side
4.2.2. Demand Side
4.3. Restraints
4.4. Opportunity
5. North America and Europe Artificial Pancreas Device System Market Analysis and Fore casts, By Disease Indication
5.1. Introduction
5.2. Basis Point Share (BPS) Analysis By Disease Indication
5.3. Y-o-Y Growth Projections By Disease Indication
5.4. Market Value Forecast By Disease Indication, 2016–2026
5.4.1. Diabetes Type 1
5.4.2. Diabetes Type 2
5.5. Prominent Trends
5.6. Market Attractiveness By Disease Indication
6. North America and Europe Artificial Pancreas Device System Market Analysis and Forecast, By Distribution Channel
6.1. Introduction
6.2. Basis Point Share (BPS) Analysis By Distribution Channel
6.3. Y-o-Y Growth Projections By Distribution Channel
6.4. Market Value Forecast By Distribution Channel, 2016–2026
6.4.1. Hospitals
6.4.2. E-Commerce
6.5. Drivers and Restraints: Impact Analysis
6.6. Market Attractiveness By Distribution Channel
7. North America and Europe Artificial Pancreas Device System Market Analysis and Forecasts, By Region
7.1. Basis Point Share (BPS) Analysis By Country
7.2. Y-o-Y Growth Projections By Country
7.3. Market Value Forecast By Region
7.3.1. North America
7.3.2. Western Europe
7.3.3. Eastern Europe
7.4. Market Attractiveness By Country/Region
8. North America Artificial Pancreas Device System Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis By Country
8.1.2. Y-o-Y Growth Projections By Country
8.1.3. Key Regulations
8.2. Market Value Forecast By Disease Indication, 2016–2026
8.2.1. Diabetes Type 1
8.2.2. Diabetes Type 2
8.3. Market Value Forecast By Distribution Channel, 2016–2026
8.3.1. Hospitals
8.3.2. E-Commerce
8.4. Market Value Forecast By Country, 2016–2026
8.4.1. The U.S.
8.4.2. Canada
8.5. Market Attractiveness Analysis
8.5.1. By Disease Indication
8.5.2. By Distribution Channel
8.5.3. By Country
8.6. Drivers and Restraints: Impact Analysis
9. Western Europe Artificial Pancreas Device System Market Analysis and Forecast
9.1.Introduction
9.1.1. Basis Point Share (BPS) Analysis By Country
9.1.2. Y-o-Y Growth Projections By Country
9.1.3. Key Regulations
9.2.Market Value Forecast By Disease Indication, 2016–2026
9.2.1. Diabetes Type 1
9.2.2. Diabetes Type 2
9.3.Market Value Forecast By Distribution Channel, 2016–2026
9.3.1. Hospitals
9.3.2. E-Commerce
9.4.Market Value Forecast By Country, 2016–2026
9.4.1. Germany
9.4.2. France
9.4.3. Italy
9.4.4. Spain
9.4.5. The U.K.
9.4.6. BENELUX
9.4.7. Rest of Western Europe
9.5.Market Attractiveness Analysis
9.5.1. By Disease Indication
9.5.2. By Distribution Channel
9.5.3. By Country
9.6. Drivers and Restraints: Impact Analysis
10. Eastern Europe Artificial Pancreas Device System Market Analysis and Forecast
10.1.Introduction
10.1.1. Basis Point Share (BPS) Analysis By Country
10.1.2. Y-o-Y Growth Projections By Country
10.1.3. Key Regulations
10.2.Market Value Forecast By Disease Indication, 2016–2026
10.2.1. Diabetes Type 1
10.2.2. Diabetes Type 2
10.3.Market Value Forecast By Distribution Channel, 2016–2026
10.3.1. Hospitals
10.3.2. E-Commerce
10.4.Market Value Forecast By Country, 2016–2026
10.4.1. Russia
10.4.2. Poland
10.4.3. Rest of Eastern Europe
10.5.Market Attractiveness Analysis
10.5.1. By Disease Indication
10.5.2. By Distribution Channel
10.5.3. By Country
10.6. Prominent Trends
10.7. Drivers and Restraints: Impact Analysis
11. Competition Landscape
11.1.Competition Dashboard
11.2.Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
11.2.1. Medtronic Plc.
11.2.2. Johnson and Johnson Services Inc.
11.2.3. Dexcom Inc.
11.2.4. Insulet Corporation
11.2.5. Tandem Diabetes Care Inc.
11.2.6. Cellnovo
12. Assumptions and Acronyms Used
13. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 1: List of artificial pancreas device system (APDS) in pipeline
Table 2: North America and Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015–2026
Table 3: North America and Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015–2026
Table 4: North America and Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Region, 2015–2026
Table 5: North America Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2026
Table 6: North America Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015–2026
Table 7: North America Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015 – 2026
Table 8: Western Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2026
Table 9: Western Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015–2026
Table 10: Western Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015 – 2026
Table 11: Eastern Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Country, 2015–2026
Table 12: Eastern Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Disease Indication, 2015–2026
Table 13: Eastern Europe Artificial Pancreas Device System Market Value (US$ Mn) Analysis and Forecast By Distribution Channel, 2015 – 2026
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 1: North America and Europe Artificial Pancreas Device System Market Value (US$ Mn) Forecast 2016 and 2026
Figure 2 : North America and Europe Artificial Pancreas Device System Market Split By Disease Indication (2015)
Figure 3 : North America and Europe Artificial Pancreas Device System Market Split By Distribution Channel (2015)
Figure 4: North America and Europe Artificial Pancreas Device System Market Split By Region (2015)
Figure 5: North America and Europe Artificial Pancreas Device System Market Value Analysis and Forecast, 2015–2026 (US$ Mn)
Figure 6: North America and Europe Artificial Pancreas Device System Market Size (US$ Mn) By Disease Indication, 2016 & 2026
Figure 7: North America and Europe Artificial Pancreas Device System Market Share Analysis (%) Disease Indication, 2016 & 2026
Figure 8: North America and Europe Artificial Pancreas Device System Market Y-o-Y Growth (%) By Disease Indication, 2015–2026
Figure 9: North America and Europe Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn) By Diabetes Type 1, 2015 – 2026
Figure 10: North America and Europe Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn) Segment, By Diabetes Type 2 2015 –2026
Figure 11: North America and Europe Artificial Pancreas Device System Market Attractiveness Analysis By Disease Indication, 2016–2026
Figure 12: North America and Europe Artificial Pancreas Device System Market Size (US$ Mn) By Distribution Channel, 2016 & 2026
Figure 13: North America and Europe Artificial Pancreas Device System Market Share Analysis (%) By Distribution Channel, 2016 & 2026
Figure 14: North America and Europe Artificial Pancreas Device System Market Y-o-Y Growth (%) By Distribution Channel, 2015–2026
Figure 15: North America and Europe Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn) By Hospitals Segment, 2015 – 2026
Figure 16: North America and Europe Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn) By E-Commerce Segment, 2015 – 2026
Figure 17: North America and Europe Artificial Pancreas Device System Market Attractiveness Analysis By Distribution Channel, 2016–2026
Figure 18: North America and Europe Artificial Pancreas Device System Market Size (US$ Mn) By Region, 2016 & 2026
Figure 19: North America and Europe Artificial Pancreas Device System Market Share Analysis (%) By Region, 2016 & 2026
Figure 20: North America and Europe Artificial Pancreas Device System Market Y-o-Y Growth (%) By Region, 2015–2026
Figure 21: North America Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 22: North America Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 23: Eastern Europe Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 24: North America and Europe Artificial Pancreas Device System Market Attractiveness Analysis By Region, 2016–2026
Figure 25: North America Artificial Pancreas Device System Market Share Analysis (%) By Country, 2016 & 2026
Figure 26: North America Artificial Pancreas Device System Market Y-o-Y Growth (%) By Country, 2015–2026
Figure 27: U.S. Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 28: Canada Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 29: North America Artificial Pancreas Device System Market Attractiveness Analysis By Country, 2016 – 2026
Figure 30: North America Artificial Pancreas Device System Market Attractiveness Analysis By Disease Indication 2016 – 2026
Figure 31: North America Artificial Pancreas Device System Market Attractiveness Analysis By Distribution Channel 2016 – 2026
Figure 32: Western Europe Artificial Pancreas Device System Market Share Analysis (%) By Country, 2016 & 2026
Figure 33: Western Europe Artificial Pancreas Device System Market Y-o-Y Growth (%) By Country, 2015–2026
Figure 34: Germany Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 35: France Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 36: Italy Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 37: Spain Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Figure 38: The U.K. Artificial Pancreas Device System Market Absolute $ Opportunity (US$ Mn), 2015 – 2026
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
